Singapore's Cordlife Group buys 19.9% stake in Stemlife


KUALA LUMPUR: Singapore-listed Cordlife Group Ltd, which is a service provider of umbilical cord blood and tissue banking, has emerged as a major shareholder in Stemlife Bhd with a 19.92% stake.

A filing with Bursa Malaysia on Wednesday showed Cordlife had bought 49.30 million shares on Sept 3.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Nasdaq, S&P set to open higher on tech boost, earnings glee
Sasbadi reports highest ever quarterly revenue
Aneka Jaringan leverages order book for growth
Chin Hin Group to develop two lands with combined GDV of RM1.08bil
CLMT 1Q net profit rises to RM33.49mil on higher occupancies, positive rental reversions
Ringgit ends marginally lower on firmer US dollar index
MoF: Govt to establish high-level facilitation platform to oversee potential, approved strategic investments
Meta Bright signs RM24mil leasing contract with Australia company
OCR Group to develop RM313mil residential project in Rawang
Legacy Credit emerges as substantial shareholder in VCI Global

Others Also Read